What is CBG Biotech?
CBG Biotech operates as a critical infrastructure provider for laboratory, industrial, and cannabis-focused enterprises. By engineering advanced solvent recovery and recycling systems, the company addresses the dual mandate of operational efficiency and environmental compliance. With over two decades of technical expertise, the firm has established a robust market position by offering HAP-free solvents and high-performance extraction systems. Their business model centers on reducing the overhead costs associated with chemical waste management, effectively transforming a traditional expense line into a sustainable, value-added process for their diverse client base.
How much funding has CBG Biotech raised?
CBG Biotech has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in CBG Biotech
PPP
Public-Private Partnership
What's next for CBG Biotech?
Following this late-stage financing, CBG Biotech is expected to prioritize the expansion of its manufacturing capacity and the further development of its sustainable chemical processing suite. The strategic deployment of these funds will likely focus on enhancing supply chain resilience and penetrating emerging markets where regulatory pressure for green manufacturing is intensifying. By leveraging its established technical foundation, the company is poised to transition from a specialized equipment provider to a comprehensive partner in the global circular economy, driving long-term value for stakeholders through innovation in solvent management.
See full CBG Biotech company page
